Schroder Investment Management Group Fate Therapeutics Inc Transaction History

Schroder Investment Management Group

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$9.86 - $23.83 $47,219 - $114,121	4,789 Added 3.61%	137,341 $1.39 Million
Q3 2022 Nov 10, 2022	BUY	$21.04 - $36.06 $1.44 Million - $2.48 Million	68,673 Added 107.5%	132,552 $2.97 Million
Q2 2022 Aug 11, 2022	BUY	$17.78 - $42.39 $17,744 - $42,305	998 Added 1.59%	63,879 $1.58 Million
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $459,677 - $933,918	15,493 Added 32.69%	62,881 $2.51 Million
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $715,112 - $961,754	14,948 Added 46.08%	47,388 $2.77 Million
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $1.59 Million - $2.56 Million	-26,794 Reduced 45.23%	32,440 $1.92 Million
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $956,698 - $1.32 Million	14,226 Added 31.61%	59,234 $5.14 Million
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $2.38 Million - $3.87 Million	-32,943 Reduced 42.26%	45,008 $3.71 Million
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $379,262 - $1.01 Million	-9,957 Reduced 11.33%	77,951 $7.09 Million
Q3 2020 Nov 13, 2020	BUY	$30.41 - $40.5 $228,652 - $304,519	7,519 Added 9.35%	87,908 $3.35 Million
Q2 2020 Aug 13, 2020	SELL	$20.21 - $35.23 $254,928 - $444,391	-12,614 Reduced 13.56%	80,389 $2.76 Million
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $8,640 - $15,940	500 Added 0.54%	93,003 $2.31 Million
Q4 2019 Feb 11, 2020	BUY	$13.39 - $20.73 $1.24 Million - $1.92 Million	92,503 New	92,503 $1.81 Million

176

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $123M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.